Navigation Links
New Research Will Benefit Four Million Americans Suffering from Chronic Fatigue Syndrome
Date:12/3/2008

y disease progression biomarkers, including those essential for early diagnosis.

-- Kathleen Light, PhD, of the University of Utah Health Sciences Center, who will investigate the mechanisms involved in chronic pain that afflicts 40%-70% of CFS patients. This study will determine whether receptors located on blood cells are increased and overactive in people with CFS and associated with increased pain sensitivity. Light theorizes that increases in specific receptors following exercise may be blood-based biomarkers for CFS and could lead to a medical test to identify CFS patients.

-- Marvin Medow, PhD, of New York Medical College, who will investigate how orthostatic intolerance, seen in many CFS patients, affects brain function. This study will examine if CFS patients have increased pooling of blood in the abdomen that results in reduced cerebral blood flow. Medow will also investigate physiologic and oxidative stress changes associated with disturbance in blood flow. These results will help determine if alterations in blood flow affect brain metabolism.

-- Bhubaneswar Mishra, PhD, of the Courant Institute of Mathematical Sciences at NYU, who will use state-of-the-art bioinformatics and computational biology tools to create a computational model of CFS-a kind of "Google for CFS" that will be part database, part knowledge-base, part research network. This new resource will provide a "systems view" of CFS that accumulates published CFS literature and experimental data to disentangle complex relationships among reported findings and discover causes of CFS.

-- Sanjay Shukla, PhD, of Marshfield Clinic Research Foundation, who will use metagenomics to determine if the ratio of good to bad intestinal bacteria in CFS patients is altered, and whether this imbalance in gut bacteria may be responsible for triggering CFS symptoms. Recent advances in metagenomics have
'/>"/>

SOURCE CFIDS Association of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Researchers identify cell group key to Lyme disease arthritis
2. Burnham and HeadNorth Foundation join forces to advance spinal cord research
3. Embryonic Stem Cell Research Unethical Waste of Taxpayer Money Says Americans United for Life President
4. Siskin Center for Child and Family Research to Focus on Early Childhood Development and Special Education
5. Interferon needed for cells to remember how to defeat a virus, UT Southwestern researchers report
6. MU researcher calls for increase in sexual assault awareness programs on college campuses
7. Radiological Society of North America research: Cancer risk from cardiac CT overstated
8. Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
9. Best Practice Database Adds Research Highlighting Effective Tactics of Sales Force and Manufacturing Groups in the Pharmaceutical Industry
10. Southern Research Wins $37 Million Black & Veatch Sub-Contract for Biological Threat Reduction Program
11. New Research Estimates 1500 Lives Could Be Saved Annually if the Lowest Performing Hospitals for Coronary Artery Bypass Graft Surgery Performed as Well as Top-ranking Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... pivotal Phase 2b 003-A1 study, known as the ... heavily pre-treated relapsed and refractory multiple myeloma patients. ... Joint Symposium at the 51st annual meeting of ... Orleans. Enrollment in this trial is complete (n=269), ...
(Date:12/6/2009)... clotting, or coagulation, is an important process that ... injured. Sometimes, however, clots form on the inside ... not dissolve naturally, a potentially life-threatening situation requiring ... Meeting of the American Society of Hematology reveals ... and heparin with the hope of preventing clots ...
(Date:12/6/2009)... Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... with herbal or natural sleep aids from around ... for a good cause. The submissions will be ... Aids ,Encyclopedia, by YOU, to be sold from ... will donate 100% of the proceeds ,from sales ...
(Date:12/6/2009)... Fox, LLP says dangerous substances such as asbestos have been found ... ... York, NY (PRWEB) December 6, 2009 -- As parents shop for ... reports of recalls due to lead paint or asbestos contamination, says ... visit hospital emergency rooms each year due to toy-related injuries,” says ...
(Date:12/5/2009)... ORLEANS, Dec. 5 There have been significant scientific ... experts continue to gain a better understanding of how ... options and provide patients with the best care. Research ... American Society of Hematology explores optimal induction therapies for ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8
... For statues, stress injuries come from standing in place for ... developed a way to predict such fracturing, applying the procedure ... and more accurate than previous methods. , In applying ... the researchers are also gaining new perspective on how these ...
... million patients treated at nearly 2,000 hospitals nationwide ... ... Ind., March 18 Press Ganey Associates,Inc., the health care industry,s ... Patient Perspectives on,American Health Care. The report examines patient satisfaction across ...
... Wash., March 18 As the April 15 ... allowed for long term care,insurance, according to LTC ... care insurance agency., *(PHOTO 72dpi: Send2Press.com/mediaboom/07-0807-LTCTruesdell_72dpi.jpg), ... "People with LTC policies can deduct substantial sums," ...
... NutraCea (OTC Bulletin,Board: NTRZ), a world leader in stabilized ... Crow will step down from,his role as Chief Financial Officer ... assume the role of Chief Financial Officer on that date.,Mr. ... ensure a smooth,transition of his responsibilities to Mr. Mueller., ...
... Visits, From Child Life Specialists at The Children,s ... March 16th - 23rd, PHILADELPHIA, March 17 ... involve fear and tears. At least that,s the,goal of ... Philadelphia.,This team, consisting of Certified Child Life Specialists and ...
... centre on Innovation and Technology (UNU-MERIT) and the United ... a forum on monetary prizes as an alternative to ... development. , The objective of the forum Prize or ... be used to direct pharmacuetical research to more socially ...
Other Medicine News:Health News:Tell them where it hurts 2Health News:Tell them where it hurts 3Health News:National Report on Patient Perspectives of Hospital Care Released Today 2Health News:TAX ALERT: Deductions for Long Term Care Insurance Premiums 2Health News:NutraCea Appoints New Chief Financial Officer 2Health News:NutraCea Appoints New Chief Financial Officer 3Health News:A Child's Trip to the Hospital Doesn't Always Have to Involve Fear and Tears 2Health News:A Child's Trip to the Hospital Doesn't Always Have to Involve Fear and Tears 3
(Date:12/4/2009)... Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin ... Trademark Office has allowed its patent application on a ... manufacture of the Company,s DCVax® therapeutic cancer vaccines. ... high concentration of dendritic cells (which are the critical ...
(Date:12/3/2009)... Pa., Dec. 3 Ambry Genetics and SoftGenetics ... provide extended bioinformatics genomics services using SoftGenetics, NextGENe ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20090428/LA06744LOGO ) ... team at Ambry has been providing genomics solutions ...
(Date:12/3/2009)... Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record ... of North America in Chicago. The ... capabilities of its kind, is the latest release ... Platform . ,, (Photo: ...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3GenVec Announces Second Quarter 2009 Results Conference Call 53211 1GenVec Announces Second Quarter 2009 Results Conference Call 53211 2Suicide Genes Help Slow Ovarian Tumor Growth in Mice 53210 1Suicide Genes Help Slow Ovarian Tumor Growth in Mice 53210 2CSCs FirstDoc Recognized by EMC as a Preferred Regulatory Compliance Application for Life Sciences Industry 53205 1CSCs FirstDoc Recognized by EMC as a Preferred Regulatory Compliance Application for Life Sciences Industry 53205 2CSCs FirstDoc Recognized by EMC as a Preferred Regulatory Compliance Application for Life Sciences Industry 53205 3
The full body blanket provides coverage to the entire patient....
The upper body blanket is typically used for abdominal or lower body procedures. The upper body blankets warms the upper torso and arms. A clear drape is included to cover and warm the intubated pati...
This product is for the lower body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
Medicine Products: